Swift Biosciences, Inc.: Series A $3M

Posted in I - Series A, Q - 3Q10, R - MID WEST, X - Reagent, XX - MI

Swift Biosciences (Ann Arbor, MI) a development-stage company focused on molecular biology reagents for R&D and diagnostics, closed a $3M Series A financing. Participants include DFJ Mercury.

Jan

2010

Marval Biosciences, Inc.: Series B $2.5M

Posted in I - Series B, Q - 4Q09, R - WEST, X - Imaging, XX - CA

Marval Biosciences (San Diego, CA) a preclinical-stage biopharma company focused on the reformulation of contrast dyes for CT scans using liposomal nanoparticles, closed a $2.5M Series B financing. Participants include DFJ Frontier and DFJ Mercury.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

Jan

2010

Vertos Medical, Inc.: Series D $15.5M

Posted in I - Series D, Q - 4Q09, R - WEST, X - Device (Spine), XX - CA

Vertos Medical (Aliso Viejo, CA) a commercial stage medical device company focused on providing minimally invasive alternatives for surgical procedures to treat lumbar spinal stenosis, closed a $15.5M Series D financing. Participants include Onset Ventures, CHL Medical Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

to top of page...